PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Emory University School of Medicine, Emory Clinical Cardiovascular Research Institute, Atlanta, Georgia.\', \'Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, Dallas.\', \'The University of Texas Southwestern Medical Center, Dallas.\', \'Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina.\', \'Sports Cardiology Center, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.\', \'Morristown Medical Center, Atlantic Health System, Morristown, New Jersey.\', \'Michigan Medicine, University of Michigan, Ann Arbor.\', \'Hartford Hospital, Hartford, Connecticut.\', \'Cardiovascular Performance Program, Massachusetts General Hospital, Boston.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamacardio.2020.5890
?:doi
?:hasPublicationType
?:journal
  • JAMA cardiology
is ?:pmid of
?:pmid
?:pmid
  • 33104154
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.551
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all